OrthoPediatrics (KIDS) Stock Price, News & Analysis

Company Overview

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis. OrthoPediatrics also offers unique epiphysiodesis and guided growth devices designed to correct limb length discrepancies and angular deformities in growing children. These devices are supported by accompanying instrumentation that simplifies surgical technique and enhances procedural efficiency.

OrthoPediatrics markets its products through a direct sales organization in the United States and through distributors and regional offices in Europe, Latin America and the Asia-Pacific region. The company collaborates with leading pediatric orthopedic surgeons and academic institutions to advance clinical research, refine surgical protocols and expand its product offerings. Continuous investment in R&D underpins its strategy to fill gaps in pediatric care that are often overlooked by general orthopedic manufacturers.

Led by a management team with deep expertise in the orthopedic device industry, OrthoPediatrics emphasizes quality systems, regulatory compliance and physician education. The company’s global footprint and specialized focus on the pediatric segment position it as a growing participant in the niche market of children’s orthopedics, striving to improve clinical outcomes and quality of life for young patients worldwide.

Key Stats

• Today's Range: $19.77 to $20.76
• 50-Day Range: $14.64 to $20.45
• 52-Week Range: $14.42 to $23.70
• Volume: 141,431 shs
• Average Volume: 138,605 shs
• Market Capitalization: $525.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $24.44
• Consensus Rating: Moderate Buy

OrthoPediatrics Stock Analysis - MarketRank™

OrthoPediatrics scored higher than 63% of companies evaluated by MarketBeat, and ranked 250th out of 848 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 9 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

OrthoPediatrics has a consensus price target of $24.44, representing about 19.5% upside from its current price of $20.45.

Amount of Analyst Coverage

OrthoPediatrics has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for OrthoPediatrics are expected to grow in the coming year, from ($1.13) to ($0.98) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of OrthoPediatrics is -12.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of OrthoPediatrics is -12.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

OrthoPediatrics has a P/B Ratio of 1.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.91% of the float of OrthoPediatrics has been sold short.

Short Interest Ratio / Days to Cover

OrthoPediatrics has a short interest ratio ("days to cover") of 6.91.

Change versus previous month

Short interest in OrthoPediatrics has recently decreased by 6.93%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

OrthoPediatrics does not currently pay a dividend.

Dividend Growth

OrthoPediatrics does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, OrthoPediatrics insiders have not sold or bought any company stock.

Percentage Held by Insiders

31.80% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 4/30/2026
• Today: 7/06/2026
• Next Earnings (Estimated): 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:KIDS
• CIK: 1425450
• Web: www.orthopediatrics.com
• Phone: (574) 268-6379
• Fax: 574-269-3692
• Employees: 200
• Year Founded: 2006

Price Target and Rating

• Average Price Target for OrthoPediatrics: $24.44
• High Price Target: $34.00
• Low Price Target: $17.00
• Potential Upside/Downside: +19.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.73
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.68)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$39.65 million
• Net Margins: -16.31%
• Pretax Margin: -16.27%
• Return on Equity: -7.01%
• Return on Assets: -4.86%

Debt

• Debt-to-Equity Ratio: 0.29
• Current Ratio: 5.21
• Quick Ratio: 2.37

Sales & Book Value

• Annual Sales: $236.35 million
• Price / Sales: 2.22
• Cash Flow: $0.17 per share
• Price / Cash Flow: 119.97
• Book Value: $13.82 per share
• Price / Book: 1.48

Miscellaneous

• Outstanding Shares: 25,680,000
• Free Float: 17,517,000
• Market Cap: $525.16 million
• Optionable: Optionable
• Beta: 0.99